Patents by Inventor Timothy S. Bringman

Timothy S. Bringman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 14-beta-gal mammalian lectins
    Patent number: 5587460
    Abstract: Human HL-60 lectin having an amino acid sequence different from other known animal lectins is disclosed. This is one member of a class of mammalian lectins extractable in lactose or detergent and specific for beta-D-galactosides (14-beta-gal lectin which contains at least one glycosylation site). Recombinant methods and materials for production of the mammalian 14-beta-gal lectins, especially HL-60 lectin, in a variety of hosts, and methods to utilize the resulting lectins are also described. Human HL-60 lectin is found in HL-60 cells and in placental tissue.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: December 24, 1996
    Assignee: Incyte Pharmaceutical Corporation
    Inventors: Glenn E. Nedwin, Timothy S. Bringman, Pierre-Oliver Couraud
  • Anti-lymphotoxin
    Patent number: 4959457
    Abstract: Antibody is provided which is capable of neutralizing the in vitro anti-neoplastic cellular activity of lymphotoxin. This antibody, which preferably is produced of monoclonal fusions, can be used in assays for lymphotoxin or for immunoaffinity purification of lymphotoxin.
    Type: Grant
    Filed: May 31, 1984
    Date of Patent: September 25, 1990
    Assignee: Genentech, Inc.
    Inventor: Timothy S. Bringman